Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03504800 · ClinicalTrials.gov registry record
OCT in Diagnosis of Irregular Corneas
A clinical trial of Keratoconus and Corneal Opacity, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 445
- Enrollment target
- 1
- Study location
NCT03504800 is a study of Keratoconus and Corneal Opacity that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 445 participants, below the 1,159-participant average among 21 other Keratoconus trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03504800, a study of Keratoconus and Corneal Opacity, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 445 participants
- Enrollment target
- 1
- Study location
Study Summary
This main goal of this study is to improve the detection, classification, monitoring, and treatment of irregular corneas due to keratoconus, warpage, dry eye, scar, stromal dystrophies, and other corneal conditions. The primary goal will be achieved by using optical coherence tomography (OCT) to: 1. Develop an OCT-based system to classify and evaluate corneal-shape irregularities. 2. Develop OCT metrics for more sensitive detection of keratoconus progression. 3. Develop OCT-and-topography guided phototherapeutic keratectomy (PTK) for irregular corneas.
Conditions Studied
Interventions
- DEVICE Optical Coherence Tomography
Study Locations (1)
Oregon
- Humberto Martinez - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 445 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2031-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03504800
The ClinicalTrials.gov registry entry for NCT03504800 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 445 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,159-participant average among 21 other Keratoconus trials with a reported enrollment target (62% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Keratoconus appearing as the primary indexed condition, and to 1 intervention - of which Optical Coherence Tomography is the first listed.
NCT03504800 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT03504800 about?
NCT03504800 is a clinical study titled "OCT in Diagnosis of Irregular Corneas". This main goal of this study is to improve the detection, classification, monitoring, and treatment of irregular corneas due to keratoconus, warpage, dry eye, scar, stromal dystrophies, and other corneal conditions. The primary goal will be achieved by using optical coherence tomography (OCT) to: ...
What is the current status of trial NCT03504800?
This trial is currently recruiting. The enrollment target is 445 participants. The study started on 2018-05-01. Estimated completion is 2031-02-28.
What conditions does trial NCT03504800 study?
This clinical trial studies the following conditions: Keratoconus, Corneal Opacity, Corneal Dystrophy.
What interventions are being tested in trial NCT03504800?
The interventions under investigation include: Optical Coherence Tomography (DEVICE).
Who is sponsoring clinical trial NCT03504800?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03504800 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratoconus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
RECRUITING · Phase 3
-
Collagen Cross-linking in Keratoconus
RECRUITING · NA
-
Corneal Elastography and Patient Specific Modeling
RECRUITING
-
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
RECRUITING · Phase 3
-
Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.